Home > Clinical Trials

Saved trials

WITHDRAWN
NCT02493322
Efficacy and Safety of Olmesartan Associated With Chlorthalidone in Essential Arterial Hypertension Control
0 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE3)
Essential Arterial Hypertension
WITHDRAWN
NCT02483936
Efficacy and Safety of Olmesartan Associated With Chlorthalidone Versus Benicar HCT® in Essential Hypertension Control
0 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE3)
Arterial Hypertension
RECRUITING
NCT06409390
Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer
15 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
Metastatic Breast Cancer
RECRUITING
NCT05982678
Basket Study for Oligo-metastatic Breast Cancer
72 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
HER2-positive Breast Cancer
COMPLETED
NCT04644237
Trastuzumab Deruxtecan in Participants With HER2-mutated Metastatic Non-small Cell Lung Cancer (NSCLC)
152 Enrollment(s)
50 Study location(s)
INTERVENTIONAL (PHASE2)
Non-Small Cell Lung Cancer
TERMINATED
NCT05954143
Trial of BDC-1001 +/- Pertuzumab in Subjects With HER2-Positive Metastatic Breast Cancer
11 Enrollment(s)
4 Study location(s)
INTERVENTIONAL (PHASE2)
Metastatic Breast Cancer


HER2-positive Breast Cancer
RECRUITING
NCT07180264
Trastuzumab Deruxtecan in Advanced Breast Cancer
118 Enrollment(s)
1 Study location(s)
OBSERVATIONAL (None)
Advanced Breast Cancer
ACTIVE_NOT_RECRUITING
NCT04042701
DS8201a and Pembrolizumab in Participants With Locally Advanced/Metastatic Breast or Non-Small Cell Lung Cancer
115 Enrollment(s)
30 Study location(s)
INTERVENTIONAL (PHASE1)
Breast Cancer


Non-small Cell Lung Carcinoma